ANTI IL-12 / IL-23 PATHWAY

<p>Interleukin-12 (IL-12) and Interleukin-23 (IL-23) are cytokines that play pivotal roles in the immune system by promoting inflammatory responses and influencing the differentiation and activation of immune cells. These cytokines are critical in the pathogenesis of several chronic inflammatory and autoimmune diseases, including psoriasis, Crohn's disease, and ankylosing spondylitis. Inhibition of IL-12 and IL-23 has emerged as a promising therapeutic strategy to modulate the immune response and reduce inflammation. By targeting these cytokines, IL-12 and IL-23 inhibitors can prevent the activation of specific T cells and the release of pro-inflammatory cytokines, thereby alleviating symptoms and improving patient outcomes. Understanding the mechanisms and benefits of IL-12 and IL-23 inhibition is crucial for advancing the treatment of immune-mediated diseases.</p>